Lisinopril Market

Lisinopril Market Size, Share & Industry Analysis, By Source:-(Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers.) By End-User:-(Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Lisinopril market is projected to grow at a CAGR of 4.2% from 2024 to 2032, driven by the increasing global prevalence of hypertension, heart failure, and chronic kidney diseases (CKD). Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that works by blocking the enzyme responsible for converting angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to vasodilation, reduction in blood pressure, and decreased strain on the heart, making it effective in managing conditions like hypertension and heart failure.

The market for lisinopril is driven by the growing need for effective and affordable treatments for cardiovascular diseases, particularly in aging populations. In addition, lisinopril’s well-established efficacy, safety profile, and cost-effectiveness make it a preferred choice for first-line therapy in hypertension and heart failure management. The drug’s availability in generic formulations further supports its widespread use. Additionally, increasing awareness of CKD and its association with hypertension and heart failure is driving additional demand.

Regionally, North America holds the largest share of the Lisinopril market due to widespread use of ACE inhibitors, strong healthcare infrastructure, and increasing incidence of hypertension and related conditions. Europe follows closely, with significant demand driven by cardiovascular health concerns, particularly in aging populations. The Asia-Pacific region is expected to grow the fastest, supported by increasing awareness of hypertension, improving healthcare access, and expanding pharmaceutical infrastructure in countries like China and India.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Lisinopril
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Pharmaceutical Manufacturers (Branded & Generic)
    • Contract Manufacturing Organizations (CMOs)
    • Research-Grade Suppliers
  • Key End-Use Industries
    • Pharmaceutical Industry.
    • Hospitals & Clinics.
    • Research Institutions.
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Lisinopril?
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily to treat high blood pressure (hypertension), heart failure, and chronic kidney disease. It works by blocking the enzyme responsible for converting angiotensin I to angiotensin II, a hormone that causes blood vessels to constrict. By inhibiting this enzyme, Lisinopril helps relax blood vessels, lowering blood pressure, improving blood flow, and reducing the workload on the heart. It is also commonly prescribed after heart attacks to improve survival rates.
What is the market growth of Lisinopril?
The global Lisinopril market is projected to grow at a CAGR of 3.2% from 2025 to 2035, rising from USD 1.9 billion in 2025 to approximately USD 2.7 billion by 2035. The market is driven by the increasing prevalence of cardiovascular diseases, rising hypertension rates, and the growing demand for affordable generics following Lisinopril’s patent expiration.
What are the drivers of the Lisinopril market?
Key drivers include the widespread need for effective, low-cost hypertension treatments, particularly in aging populations and those with cardiovascular comorbidities. Lisinopril’s proven efficacy, low cost, and safety profile contribute to its ongoing use. The shift towards more proactive cardiovascular disease prevention and the increasing global burden of hypertension, heart failure, and kidney disease continue to support its market demand.
Who are the key players operating in the Lisinopril market?
Leading players in the Lisinopril market include Merck & Co., the original developer, which markets the branded version under the name Prinivil. Other significant manufacturers include Teva Pharmaceuticals, Sandoz (Novartis), Aurobindo Pharma, and Mylan, who provide generic versions of the drug to markets worldwide. These generics have significantly reduced the cost of treatment, contributing to wide accessibility.
Which region will exhibit the fastest growth in the Lisinopril market?
Asia-Pacific is expected to experience the fastest growth in the Lisinopril market, driven by the rising prevalence of hypertension and cardiovascular diseases, coupled with expanding healthcare access in countries like China and India. North America and Europe will maintain steady demand due to high healthcare spending and a large patient population, while Latin America and Africa are projected to see moderate growth as healthcare infrastructure improves.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.